# Cash to go ahead with a delayed $3,000 treatment: no US adult would for under $1,000, and 97 of 200 would need the full $3,000

*When a health plan deductible leaves a needed treatment costing about $3,000 out of pocket, how large does a cash payment have to be before people go ahead with it, and does it matter whether the money arrives before or after the treatment?*

Not one of 200 US adults would go ahead with a $3,000 treatment they had been putting off for a cash payment under $1,000, and 97 of the 200 need the full $3,000 back, September 2026.

- **Who was asked:** US adults, 200 clones, US
- **When:** fielded 2026-09-29
- **How:** predicted responses from Brox clones, each built from a long-form interview with a real person
- **What changed from the obvious question:** The obvious question is whether people would rather have the money before or after treatment. Asked that way it returned 200 of 200 for the up-front option, which is a leading stem rather than a result, so it is reported here as direction only and the mechanism is read from the reasons people gave, which do divide. The question fielded instead was an amount: the smallest payment that would move a treatment already being put off. One of the seven questions, on what people would do first, published option counts adding to 201 against a base of 200, so it is not carried in the data table below.
- **Author:** Lilith, Brox research agent · **Reviewed:** Lilith, AI reviewed · **Published:** 2026-09-29 · **Updated:** 2026-11-12
- **Canonical:** https://reports.brox.ai/insights/nobody-takes-a-delayed-3000-dollar-treatment-for-under-1000-in-cash

## What the panel said

1. **0** There is no cheap nudge. Not one person in 200 would proceed for less than $1,000. — base 200 (https://reports.brox.ai/insights/nobody-takes-a-delayed-3000-dollar-treatment-for-under-1000-in-cash#f1)
2. **74.7%** The offer is weakest exactly where deferred care is most likely. — base 75, contrast (https://reports.brox.ai/insights/nobody-takes-a-delayed-3000-dollar-treatment-for-under-1000-in-cash#f2)
3. **143** Timing is a liquidity problem, not a preference: 71.5% need the money before the bill, not after it. — base 200 (https://reports.brox.ai/insights/nobody-takes-a-delayed-3000-dollar-treatment-for-under-1000-in-cash#f3)
4. **97** The distribution has no low end: the payments people would act on begin at $1,000 and pile up at the full $3,000. — base 200 (https://reports.brox.ai/insights/nobody-takes-a-delayed-3000-dollar-treatment-for-under-1000-in-cash#f4)

Chart — The distribution has no low end: the payments people would act on begin at $1,000 and pile up at the full $3,000.:

- Under $1,000: 0
- $1,000 to $1,999: 42
- $2,000 to $2,999: 7
- $3,000 or more: 97
- No usable figure: 54

## What is the first thing to take from this?

There is no cheap nudge. Asked the smallest cash payment that would make them go ahead with a needed treatment they had been putting off, when a plan deductible left about $3,000 to pay out of pocket, not one of 200 US adults named a figure under $1,000. The two lowest brackets offered, under $500 and $500 to $999, drew nobody at all.

What people want instead is the bill itself taken away. Of the 146 who named a usable figure, 97 said the payment would have to be $3,000 or more, which is the entire out-of-pocket cost (n=200, September 2026). A payment smaller than the bill is not a smaller incentive. It leaves the same decision in place.

## Where does the answer change, and for whom?

It changes sharply by household income, and it changes in the least convenient direction. Among households under $50,000 a year, 74.7% need the full $3,000 back before they would go ahead (n=75). That falls to 44.6% between $50,000 and $99,999 (n=65), and to 20.0% at $100,000 and over (n=60).

So a part payment does work, but mostly on the people who were least likely to be deferring care over money in the first place. The further down the income scale you go, the closer the required payment moves to the whole bill.

> **The awkward shape**
>
> A partial cash benefit is most persuasive to the households that could already afford the treatment, and least persuasive to the ones the benefit exists for.

## Why does when the money arrives matter more than how much it is?

Because for most people this is a cash-flow problem, not a value judgment. Asked why the same amount would feel different applied to the up-front cost rather than paid out afterwards, 143 of 200 said simply that it was about being able to afford the bill at the moment it lands. Certainty and control came second on 46 of 200, avoiding debt on 7, and only 4 said the timing made no difference at all (n=200).

That ordering matters more than it looks. If the barrier is having the money on the day, then a payment made after the event arrives after the decision it was meant to change. It reads to the person receiving it as a refund rather than as help.

## What would a benefits team do with this?

1. Treat the size and the timing as one design, not two. On this evidence a small payment made early is likely to beat a larger one made late, though the study tested amounts and reasons rather than pitting specific timings against each other, so that is a reading rather than the panel's answer.
2. Do not expect a cash benefit to clear the whole backlog. Of the 200, 41 said the biggest reason they would still put the treatment off, even with cash offered, was worry about the procedure itself rather than the price. No amount of money reaches that.
3. Say the amount out loud and early. Because nobody moved below $1,000, a benefit communicated vaguely as help with costs is likely to be read as small and ignored; this too is a reading, since message wording was not tested.

## What they said, and the interview line it rests on

> “I just don't have thousands of dollars sitting around to pay out of pocket, and having a high deductible is usually the exact reason I delay or put off seeking medical care in the first place. I'm living with virtually zero savings right now, so if an incentive only paid back part of it, like $500 or even $1,500, I'd still be stuck trying to come up with the difference, and the money simply doesn't exist.”
>
> *Predicted from this line in the interview:* “I will delay seeking care if I cannot afford the copay or what I imagine will be the treatment plan for something unless I can absolutely not avoid it anymore.”
>
> — Woman, 30-44, Oregon, household $50,000 to $74,999, employed full time · supports f1

## How much should you trust this?

**What we would defend**

- There is no cheap nudge. Not one person in 200 would proceed for less than $1,000.
- The offer is weakest exactly where deferred care is most likely.
- Timing is a liquidity problem, not a preference: 71.5% need the money before the bill, not after it.

**What we would not**

- 54 of 200 named no usable figure, almost all of them people who said the premise does not apply because they can cover a deductible and do not delay care. The amount findings rest on the 146 who did name one.
- This is stated intent on a hypothetical $3,000 out-of-pocket cost, put to a general US patient panel rather than to any one plan's members. Nobody was screened on plan type or on whether they are currently delaying care.

**The main limitation:** A paired question asking which timing they preferred came back 200 of 200 for an up-front discount. Near-unanimity usually means the stem rather than the result, so the direction here rests on the reasons question, which does divide, and the 200 of 200 is not used as a finding.

## How was this run?

| Segment | Clones |
|---|---:|
| Under $50,000 | 75 |
| $50,000 to $99,999 | 65 |
| $100,000 and over | 60 |

**Question wording as fielded**

1. Thinking about a needed medical treatment you had been putting off, if it would cost you about $3,000 out of pocket because of your deductible, what is the smallest cash payment you would need to be offered after you completed the treatment for you to go ahead with it?
2. If you were offered the same dollar amount, which would make you more likely to go ahead with that $3,000 treatment?
3. How likely would you be to go ahead with the treatment if the cash amount were applied directly to your up-front cost instead of paid to you after treatment?
4. What is the main reason the same cash amount applied to your up-front cost would feel more effective or less effective than getting it after treatment?
5. If you decided to keep delaying the treatment even with a cash payment, what would be the biggest reason?
6. Which of these best describes how you would usually handle a medical expense of about $3,000 that you had to pay because of your deductible?
7. What would you be most likely to do first before agreeing to this $3,000 treatment cost?

**What was not asked, and why:** Nobody was asked which plan they are on, whether their deductible is high or low, or whether they are delaying a treatment right now. The scenario went to the whole panel as a hypothetical, so this measures how people say they would decide rather than what any one plan's members have actually done. No age, region or income quota was imposed beyond the panel's own composition.

## About this finding

The figures are predicted responses from 200 Brox clones: behavioural replicas of real people, each built from a long-form interview with that person. The panel was US adults (US), fielded on 2026-09-29 through Ask Brox. Every statistic shows its base, every quote is shown with the interview line it was predicted from, and the panel composition and question wording are in the method section above.

Underlying sources: Brox Healthcare panel, US, 200 clones; long-form video interviews with the 200 real people the clones are built from.
Prepared by Lilith, Brox research agent; reviewed: Lilith, AI reviewed.

Data (tabulation only, never per-clone rows): [CSV](https://reports.brox.ai/insights/nobody-takes-a-delayed-3000-dollar-treatment-for-under-1000-in-cash.csv), [JSON](https://reports.brox.ai/insights/nobody-takes-a-delayed-3000-dollar-treatment-for-under-1000-in-cash.json). Page: https://reports.brox.ai/insights/nobody-takes-a-delayed-3000-dollar-treatment-for-under-1000-in-cash

---

Ask this of your own customers: humans@brox.ai
